Advanced Search
Contact | Corporate | Help

Daily news email for April 13, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Genentech and Pfizer Share CDx Success Insights at the 4th Molecular Diagnostics for Cancer ...

Biotage Unveils Isolera (TM) Spektra with Full PDA Spectral Scanning

Results of Letermovir (AIC246) Phase 2b in Prophylaxis of Human Cytomegalovirus in Recipients ...

BioRN Annual Conference 2012: Mobilizing Seed and Venture Capital for Health Innovation

Cellmid Launches Évolis (TM) Hair Products

 BioSpace
Left Hand Right Hand, Premature Babies Make the Link, Centre National de la Recherche Scientifique Study

Sanofi (France) Seeks French Government Aid on Indian Tax

Rib-X Pharmaceuticals, Inc. Appoints Infectious Disease Expert and Former FDA Deputy Director MD as Chief Development Officer

Engineered Stem Cells Seek Out, Kill HIV in Living Organisms, University of California, Los Angeles (UCLA) Study

National Institutes of Health (NIH) Chief Encourages Drugmakers to "Open Their Drug Freezers" to Discover "New" Drugs

BioSpace - Breaking News
Affymax, Inc. and Takeda Pharmaceutical Co. Ltd. Announce Centers for Medicare and Medicaid Services Has Assigned a Q-Code for OMONTYS (Peginesatide) Injection

USPTO Affirms Gevo, Inc.'s Request for Reexamination of Butamax Patent

Mylan Inc. Launches First Generic Version of Lescol(R) Capsules

Rock Creek Pharmaceuticals Announces Market Entry of AnatablocUnflavored as the First Brand Extension of its AnatablocProduct Line

Quantum Genomics Corp. Announces Initiation of a First-in-Human Clinical Study With QGC001, Its Lead Compound for the Treatment of Hypertension

Biotech News - Business Wire
GE Healthcare versterkt O&O-inspanningen voor ziekte van Alzheimer

RBCC and N3D Forge Ahead with Bold Growth Strategy

GE Healthcare renforce ses efforts de R&D en faveur de la maladie d'Alzheimer

GE Healthcare accresce il suo impegno nella ricerca e nello sviluppo contro l'Alzheimer

GE Healthcare refuerza sus iniciativas de I+D en la enfermedad del Alzheimer

 Biotech News - PR Newswire
Lilly's John Lechleiter Becomes PhRMA Board Chairman; Robert J. Hugin, Ian Read Assume New Posts

Mylan Launches First Generic Version of Lescol® Capsules

Urologists Debunk Misleading, Grossly Inaccurate Prostate Cancer Biopsy Study

Potassium Iodide Sales Surge on Heels of Large Government Order

Cempra, Inc. to Present at the BioCentury Future Leaders Conference
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
BARDA Cuts Funding for Radiation Poisoning Treatment

Covidien Looks to Israel for Novel Medical Devices

New Report Finds Prescription Drug Spending Flat

US Unveils $200 Million Big Data Initiative

GE Expands Diagnostic Business with SeqWright Buy

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Research and Markets: Arrhythmias Global Clinical Trials Review, H1, 2012

Research and Markets: Appendicitis Global Clinical Trials Review, H1, 2012

Multi-Site Study at ASBD Reports Favorable SAVI Data

RaySearch Laboratories: Breakthrough order for RayStation® in Asia

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Medical Lasers and Light Based Systems

 Clinical Trials - PR Newswire
PhRMA Statement Regarding Research Partnerships and Clinical Trials

Montefiore Study Reveals High Rate of Anal Cancer in HIV-positive Women

Thought Leaders in Radiation Medicine Convene to Discuss Safety and Advancements in Cancer Treatment

Nuvo Research Provides Pennsaid® Update

Cancer Therapy Gets a Boost from New Isotope

 CNN Top Stories
Pakistan to deport Bin Laden's widows

Rocket fails; U.N. to meet

Analyst: N. Korea may test nuke now

Zimmerman to seek bond in Martin case

Syrians take to streets amid truce
Contract Pharma
Michael Griffith Joins Repligen Board

Quintiles Named Best CRO In Vaccine Excellence

Jubilant Inaugurates Gujarat SEZ

SNBL USA Expands Business Development Team

Richman Chemical, Auditweaver In Software Pact

 FDA Drugs- What's New
FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para Celexa (citalopram bromhidrato) relacionadas con el riesgo potencial de ritmo cardiaco anormal con dosis altas

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses

 FDA News - Business Wire
Rib-X Pharmaceuticals Appoints Infectious Disease Expert and Former FDA Deputy Director Matthew Wikler, MD as Chief Development Officer

InVivo Therapeutics Expects to Commence Human Study after Meeting on IDE Filing for Biopolymer Scaffolding to Treat Spinal Cord Injuries

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval

22ndFDA
FDA Press Releases
Dept. of Justice enters consent decree with California seafood processor

FDA takes steps to protect public health

FDA approves imaging drug Amyvid

FDA enters consent decree with cheese producer due to Listeria contamination

FDA announces plans to pilot end-stage kidney disease technology in new program

 FDA Vaccines, Blood and Biologics - What's New
FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

 FierceBiotech
Sanofi CEO touts partnership drugs as pipeline standouts

Google VC eyes biotech in data analytics push

UPDATED: Tioga nabs $10M VC deal amid PhIII for bowel disorder drug

Lilly CEO avoids Pfizer-like cuts, focuses on pipeline

Embattled AZ chief: Bigger R&D bets, megadeals not the answer
FierceBiotech IT
Amazon hungers for genomics data after NIH pact

Google VC doubles down on Big Data after biotech bets

Wellcome joins chorus calling for free online access to medical research

Big Pharmas back open source drug discovery with money and molecules

Gotham's genome center grabs grant for bioinformatics hires

 FierceBiotech Research
Novel drug blasts leukemia in zebra fish

Novel drug blasts leukemia in zebrafish

Three studies back notion of autism erupting from genetic mutations

Tarantula venom, baking soda explored to fight breast cancer

Salk scientists eye 2 new targets against type 2 diabetes

 FiercePharma
Reuters: Money lined up for Watson to buy Actavis

You can't cut your way to success, Lilly CEO declares

Novartis reports patient taking Gilenya developed rare brain disease

Icahn seeks records on why Amylin said no to Bristol-Myers

Bloomberg: Bayer to pay $110 million to get out from under 500 Yaz lawsuits
FiercePharma Manufacturing
Surya Pharmaceuticals closes 2 Indian API plants

PET drug producers under gun to meet FDA rule

3 big animal drugmakers volunteer to change labels

Malaysian genericsmaker in talks to buy manufacturing facility in Indonesia

Some supply issues expected from Teva plant in Croatia

 FierceVaccines
Biovest plans Canadian submission for personalized cancer vax

HIV vaccines: When is a failure actually a success

Vaccine approach could trick immune system

Asthma vaccine hopes rise in preclinical trials

'Universal' cancer vaccine not miraculous but could bring hope

 Health News - BizJournals.com
AmMed agrees to pay $18 million in health care settlement

Briefcase Plus: WorldDenver to attract international business people

Photos: Johns Hopkins dedicates $1.1 billion patient towers

Hyperion Therapeutics seeks $57.5 million IPO

Top 5: Central Florida's largest hospitals
Health News - CNBC
Top Cities for Job Growth

Arkansas not counting on $1.2B from drug trial yet

Most Americans back gun lobby, right to use deadly force

Sebelius seeks civil rights support for U.S. healthcare law

Cramer's Growth Play on Celgene

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Roche Reports Sales Dip in First Quarter of This Year

Shire to Purchase Substantially All Pervasis Assets to Fortify Regenerative Medicine Business

GEN Poll Majority Favors Moratorium on Synthetic Bio Products

VC Firm Flagship Ventures Joins a Merck Fund in Launching Biotech Startups

Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote for the Election of All Illumina Nominees Using Management's WHITE Proxy Card
Marketwire - Pharma and Biotech
Addex Takes Steps to Rightsize Operations and Position the Company for Future Success

DHS Holding, Co. Retires 50 Million Shares

Break-Through Invention for Treating Cancer -- Australian Biotech Company Completes Round 1 Funding

Genetic Technologies' Subsidiary Update

Theratechnologies Announces Financial Results for First Quarter of 2012

 MassBio News
New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

By Popular Demand: New Professional Development Courses Aim to Meet Industry Needs

10 reasons to attend bio international convention

BioPharm America 2012

 Medical Pharma - PR Newswire
California Medical/Urgent Care Provider Creates Free 'Safety Net' to Help Uninsured

Excessive Worrying May Have Co-Evolved With Intelligence

Chromogenex Receives FDA Clearance for Circumferential Reduction for i-Lipo Body Contouring System

Delcath Announces First Patient Treatment Using Second Generation Hemofiltration Cartridge

Unilife Corporation to Announce Financial Results for Fiscal 2012 Third Quarter on Thursday, April 26, 2012
National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

 Nature Biotechnology
Use of genome-wide association studies for drug repositioning

The art of the alliance

Addgene provides an open forum for plasmid sharing

Tensha Therapeutics

Positive signals from Washington

 New York Times- Biotechnology
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge
New York Times- Pharmaceuticals
Managing Pain

Rite Aid Improved Sales in Fourth Quarter

States Seek to Curb Exorbitant Drug Costs Incurred by Patients

Drug Giant Is Fined $1.2 Billion in Risperdal Case

Drug Giant Is Fined $1.2 Billion in Arkansas

 OnBioVC
1Q12 White Paper | A is for Innovation And

Promedior, Inc.: Series D $21.5M

Collegium Pharmaceutical, Inc.: Series B $22.5M

BioAmber, Inc.: Series C $30M

LanzaTech, Ltd.: $55.8M Series C

 Outsourcing-Pharma
People special: social media gets job hunters noticed

Regulatory changes: the experts give us their thoughts at DIA Euromeeting

Catalent eyes emerging market expansion of end-to-end development service model

Comparator sourcing is a complex challenge in a globalised market says Clinigen

Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing
Pharma News - Business Wire
Research and Markets: Pharmaceuticals - Scandinavia Industry Guide

Research and Markets: Mozambique Pharmaceuticals and Healthcare Report Q2 2012

Research and Markets: Orphan Drugs in Asia: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market 2012

Affymax and Takeda Announce Centers for Medicare and Medicaid Services Has Assigned a Q-Code for OMONTYS® (Peginesatide) Injection

U.S. Senators Carper and Coons Join Delaware Bio to Honor 2012 Annual Award Winners

 Pharma News - PharmiWeb
Tommy Chong, Rob Van Dam Seek to Free Kush With New Documentary

Bayer's Xarelto® (Rivaroxaban) Submitted for EU Marketing Authorisation for the Treatment of Pulmonary Embolism (PE) and Prevention of Recurrent Deep Vein Thrombosis (DVT) and PE in adults

Strategic Product Deployment Announcement: Clotamin

Sysmex and Roche renew successful alliance in the hematology business

Is Plastic Surgery Appropriate for Children

 Pharma News - PR Newswire
Indiens Regierungssonderkommission zur Überwachung und Nachverfolgung von Pharmazeutika empfiehlt spezifische Produktkennziffern und SMS-Authentifizierungsmodell

CX 2012: Elevating the Boundaries of Interventional Imaging with Mobile C-arms

Un groupe de travail du gouvernement indien dédié au suivi et à la traçabilité des produits pharmaceutiques recommande l'usage de codes d'identification uniques et dune authentification par SMS

Recomendaciones del grupo de trabajo del gobierno de la India sobre el seguimiento y localización farmacéutica

MAP Pharmaceuticals Provides Update on LEVADEX® Program
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

 PRWeb - Biotechnology
ITU Announces New Partnership between Digital Arts Department and...

Zemea® Propanediol Receives Natrue Certification

New Fat Graft Procedure Promises Long-Term Results in Breast...

SPIE Defense, Security and Sensing move to Baltimore gains...

Technological Medical Advancements Explained by Telemedicine Provider...
PRWeb - Pharmaceuticals
Q1Medicare.com Brings the Finalized 2013 Medicare Part D Defined...

Medical Community Supports Absorption Pharmaceuticals Latest $1...

NutraGenetics LLC Names Brian Flach National Sales Manager, Sam's Club...

Pediatric Therapy Services in Texas Support Autism Awareness

Federal Judge Schedules DePuy ASR MDL Status Conference For May 1,...

 Scientific American
Secret Computer Code Threatens Science

Fathomable Pharmaceuticals: Will Cameron's Voyage to the Bottom of the Sea Yield Breakthrough Drugs

Parsing Primates: Baboons Learn to Recognize the Difference Between Real and Fake English Words

Feeding the World, While the Earth Cooks [Live Webcast]

Bugs That Transmit "Silent Killer" Are Biting More in the U.S.

 Sports - ESPN Basketball
UConn's Drummond declares for NBA draft

Fine accuser says he made up claims of abuse

Gators star freshman Beal to enter NBA draft

Raiders sign ex-Fullerton hoops player Hardy

Colorado State introduces Eustachy as coach
Sports News - ESPN
Lawyers: Petrino won't appeal Arkansas firing

Petrino won't appeal termination, source says

Petrino in a text: 'Is the mood to fire me'

Clemson RB Ellington sidelined with ankle injury

USC's Shaw granted hardship waiver by NCAA

 Xconomy Life Sciences
Pervasis, Flagship, SeventhSense, & More Boston Life Sciences Newsmakers

Pervasis, Flagship, SeventhSense, & More Boston Life Sciences Newsmakers

Tioga Investor Thomas McNerney Keeping Busy After San Diego Move

Provid Pharma Leans on MS Society's Venture Fund to Boost Lead Drug

SD Life Sciences Roundup: Optimer, Illumina, & Deals, Deals, Deals

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012